Interpharm Holdings, Inc.
IPAH · OTC
6/30/2007 | 6/30/2006 | 6/30/2005 | 6/30/2004 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 19.3% | 58.7% | -2.9% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 28.7% | 27.5% | 22.7% | 23.8% |
| EBITDA | -$0 | -$0 | $0 | $0 |
| % Margin | -10.8% | -5.1% | 2.9% | 14.5% |
| Net Income | -$0 | -$0 | -$0 | $0 |
| % Margin | -18.6% | -6% | -0.4% | 7.6% |
| EPS Diluted | -0.26 | -0.15 | -0.01 | 0.04 |
| % Growth | -73.3% | -1,400% | -125% | – |
| Operating Cash Flow | -$0 | $0 | -$0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |